연구동향 분석

Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model

정윤석 이태용 강호철 2015년

논문상세정보
인용/피인용
' Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • biomechanicalproperties
  • immunocompetentrodentmodel
  • micro-ct
  • tumor-induced osteolysis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,608 0

0.0%

' Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model' 의 참고문헌

  • Toxic effect of an antitumor drug paclitaxel on morphofunctional characteristics of the liver in rats
    Ermolaeva LA Bull Exp Biol Med 145 : 263 ~ 265 [2008]
  • Toxic effect of an antitumor drug paclitaxel on morphofunctional characteristics of the liver in rats
    Ermolaeva LA Bull Exp Biol Med 145 263-265 [2008]
  • The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma
    Jaganjac M Cancer Lett 260 : 180 ~ 186 [2008]
  • The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma
    Jaganjac M Cancer Lett 260 180-186 [2008]
  • The effect of an osteolytic tumor on the threedimensional trabecular bone morphology in an animal model
    Kurth AA Skeletal Radiol 30 : 94 ~ 98 [2001]
  • The effect of an osteolytic tumor on the threedimensional trabecular bone morphology in an animal model
    Kurth AA Skeletal Radiol 30 94-98 [2001]
  • The bisphosphonate ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by 45Ca kinetics in the intact rat
    Fleisch H Osteoporos Int 6 : 166 ~ 170 [1996]
  • The bisphosphonate ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by 45Ca kinetics in the intact rat
    Fleisch H Osteoporos Int 6 166-170 [1996]
  • Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis
    Arrington SA Bone 38 : 359 ~ 367 [2006]
  • Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis
    Arrington SA Bone 38 359-367 [2006]
  • Taxol inhibits osteoclastic bone resorption
    Hall TJ Calcif Tissue Int 57 : 463 ~ 465 [1995]
  • Taxol inhibits osteoclastic bone resorption
    Hall TJ Calcif Tissue Int 57 463-465 [1995]
  • Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis
    Chanda D Mol Ther 16 : 871 ~ 878 [2008]
  • Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis
    Chanda D Mol Ther 16 871-878 [2008]
  • Site-specific human breast cancer (MDA-MB-231) metastases in nude rats:model characterisation and in vivo effects of ibandronate on tumour growth
    Neudert M Int J Cancer 107 : 468 ~ 477 [2003]
  • Site-specific human breast cancer (MDA-MB-231) metastases in nude rats:model characterisation and in vivo effects of ibandronate on tumour growth
    Neudert M Int J Cancer 107 468-477 [2003]
  • Selective modification of bone quality by PTH, pamidronate, or raloxifene
    Brennan TC J Bone Miner Res 24 : 800 ~ 808 [2009]
  • Selective modification of bone quality by PTH, pamidronate, or raloxifene
    Brennan TC J Bone Miner Res 24 800-808 [2009]
  • Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption
    Strube A Clin Cancer Res 15 : 3751 ~ 3759 [2009]
  • Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption
    Strube A Clin Cancer Res 15 3751-3759 [2009]
  • Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption
    Alvarez E Clin Cancer Res 9 : 5705 ~ 5713 [2003]
  • Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption
    Alvarez E Clin Cancer Res 9 5705-5713 [2003]
  • Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis
    Kurth AA J Bone Miner Metab 25 : 86 ~ 92 [2007]
  • Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis
    Kurth AA J Bone Miner Metab 25 86-92 [2007]
  • Predicting failure load of the femur with simulated osteolytic defects using noninvasive imaging technique in a simplified load case
    Lee T Ann Biomed Eng 35 : 642 ~ 650 [2007]
  • Predicting failure load of the femur with simulated osteolytic defects using noninvasive imaging technique in a simplified load case
    Lee T Ann Biomed Eng 35 642-650 [2007]
  • Predicting distal femur bone strength in a murine model of tumor osteolysis
    Mann KA Clin Orthop Relat Res 466 : 1271 ~ 1278 [2008]
  • Predicting distal femur bone strength in a murine model of tumor osteolysis
    Mann KA Clin Orthop Relat Res 466 1271-1278 [2008]
  • Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel
    Steed H Pharmacogenomics 8 : 803 ~ 815 [2007]
  • Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel
    Steed H Pharmacogenomics 8 803-815 [2007]
  • Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis
    Heldman AW Circulation 103 : 2289 ~ 2295 [2001]
  • Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis
    Heldman AW Circulation 103 2289-2295 [2001]
  • Ovarian toxicity of paclitaxel and effect on fertility in the rat
    Tarumi W J Obstet Gynaecol Res 35 : 414 ~ 420 [2009]
  • Ovarian toxicity of paclitaxel and effect on fertility in the rat
    Tarumi W J Obstet Gynaecol Res 35 414-420 [2009]
  • Novel approach of predicting fracture load in the human proximal femur using non-invasive QCT imaging technique
    Lee T Ann Biomed Eng 37 : 966 ~ 975 [2009]
  • Novel approach of predicting fracture load in the human proximal femur using non-invasive QCT imaging technique
    Lee T Ann Biomed Eng 37 966-975 [2009]
  • Morphological and mechanical changes in ovariectomized rat tibia with treatments of ibandronate and parathyroid hormone
    Yang X Osteoporosis 8 : 255 ~ 265 [2010]
  • Morphological and Mechanical Changes in Ovariectomized Rat Tibia with Treatments of Ibandronate and Parathyroid Hormone
    Xiao Yang OSTEOPOROSIS 8 3 255-265 [2010]
  • Mechanisms of bone metastasis
    Mundy GR Cancer 80 (8Suppl) : 1546 ~ 1556 [1997]
  • Mechanisms of bone metastasis
    Mundy GR Cancer 80 8Suppl 1546-1556 [1997]
  • Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
    Russell RG Osteoporos Int 19 : 733 ~ 759 [2008]
  • Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
    Russell RG Osteoporos Int 19 733-759 [2008]
  • Localized sclerotic bone response demonstrated reduced nanomechanical creep properties
    Chen X J Mech Behav Biomed Mater 17 : 198 ~ 208 [2013]
  • Localized sclerotic bone response demonstrated reduced nanomechanical creep properties
    Chen X J Mech Behav Biomed Mater 17 198-208 [2013]
  • Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats
    Lalla S Osteoporos Int 8 : 97 ~ 103 [1998]
  • Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats
    Lalla S Osteoporos Int 8 97-103 [1998]
  • Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer
    Halvorson KG J Pain Symptom Manage 36 : 289 ~ 303 [2008]
  • Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer
    Halvorson KG J Pain Symptom Manage 36 289-303 [2008]
  • Intravenous aminobisphosphonates for managing complications of malignant osteolysis in companion animals
    Fan TM Top Companion Anim Med 24 : 151 ~ 156 [2009]
  • Intravenous aminobisphosphonates for managing complications of malignant osteolysis in companion animals
    Fan TM Top Companion Anim Med 24 151-156 [2009]
  • Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?
    Shord SS Biopharm Drug Dispos 27 : 191 ~ 196 [2006]
  • Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?
    Shord SS Biopharm Drug Dispos 27 191-196 [2006]
  • Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis
    Zheng Y Bone 40 : 471 ~ 478 [2007]
  • Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis
    Zheng Y Bone 40 471-478 [2007]
  • Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat
    Jung A Cancer Res 44 : 3007 ~ 3011 [1984]
  • Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat
    Jung A Cancer Res 44 3007-3011 [1984]
  • Ibandronate: pharmacology and preclinical studies
    Russell RG Bone 38 (4 Suppl 1) : S7 ~ S12 [2006]
  • Ibandronate: pharmacology and preclinical studies
    Russell RG Bone 38 4 Suppl 1 S7-S12 [2006]
  • Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat
    Kurth AA Bone 30 : 300 ~ 306 [2002]
  • Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat
    Kurth AA Bone 30 300-306 [2002]
  • Ibandronate in metastatic bone disease: a review of preclinical data
    Bauss F Anticancer Drugs 16 : 107 ~ 118 [2005]
  • Ibandronate in metastatic bone disease: a review of preclinical data
    Bauss F Anticancer Drugs 16 107-118 [2005]
  • Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study
    Yang X Bone 48 : 1154 ~ 1163 [2011]
  • Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study
    Yang X Bone 48 1154-1163 [2011]
  • Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis
    Chavassieux PM J Clin Invest 100 : 1475 ~ 1480 [1997]
  • Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis
    Chavassieux PM J Clin Invest 100 1475-1480 [1997]
  • Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    Winter MC Cancer Treat Rev 34 : 453 ~ 475 [2008]
  • Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    Winter MC Cancer Treat Rev 34 453-475 [2008]
  • Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer
    Bussard KM J Mammary Gland Biol Neoplasiam 14 : 387 ~ 395 [2009]
  • Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer
    Bussard KM J Mammary Gland Biol Neoplasiam 14 387-395 [2009]
  • Estradiol influences the mechanical properties of human fetal osteoblasts through cytoskeletal changes
    Muthukumaran P Biochem Biophys Res Commun 423 : 503 ~ 508 [2012]
  • Estradiol influences the mechanical properties of human fetal osteoblasts through cytoskeletal changes
    Muthukumaran P Biochem Biophys Res Commun 423 503-508 [2012]
  • Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules
    Peltier S Pharm Res 23 : 1243 ~ 1250 [2006]
  • Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules
    Peltier S Pharm Res 23 1243-1250 [2006]
  • Effects of alendronate and taxol on PC-3ML cell bone metastases in SCID mice
    Stearns ME Invasion Metastasis 16 : 116 ~ 131 [1996]
  • Effects of alendronate and taxol on PC-3ML cell bone metastases in SCID mice
    Stearns ME Invasion Metastasis 16 116-131 [1996]
  • Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system
    Hall DG J Bone Miner Res 9 : 221 ~ 230 [1994]
  • Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system
    Hall DG J Bone Miner Res 9 221-230 [1994]
  • Effect of ibandronate and hPTH on the viscoelastic response of ovariectomized rat femur
    Yang X Osteoporosis 9 : 222 ~ 230 [2011]
  • Effect of Ibandronate and hPTH on the Viscoelastic Response of Ovariectomized Rat Femur
    이태용 OSTEOPOROSIS 9 3 222-230 [2011]
  • Differential effects of bisphosphonates on breast cancer cell lines
    Verdijk R Cancer Lett 246 : 308 ~ 312 [2007]
  • Differential effects of bisphosphonates on breast cancer cell lines
    Verdijk R Cancer Lett 246 308-312 [2007]
  • Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases
    Boissier S Cancer Res 60 : 2949 ~ 2954 [2000]
  • Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases
    Boissier S Cancer Res 60 2949-2954 [2000]
  • Bisphosphonates induce breast cancer cell death in vitro
    Fromigue O J Bone Miner Res 15 : 2211 ~ 2221 [2000]
  • Bisphosphonates induce breast cancer cell death in vitro
    Fromigue O J Bone Miner Res 15 2211-2221 [2000]
  • Biochemical markers of bone metabolism in animals:uses and limitations
    Allen MJ Vet Clin Pathol 32 : 101 ~ 113 [2003]
  • Biochemical markers of bone metabolism in animals:uses and limitations
    Allen MJ Vet Clin Pathol 32 101-113 [2003]
  • Assessing the susceptibility to local buckling at the femoral neck cortex to age-related bone loss
    Lee T Ann Biomed Eng 37 : 1910 ~ 1920 [2009]
  • Assessing the susceptibility to local buckling at the femoral neck cortex to age-related bone loss
    Lee T Ann Biomed Eng 37 1910-1920 [2009]
  • Antitumour effects of bisphosphonates: first evidence and possible mechanisms
    Diel IJ. Drugs 59 : 391 ~ 399 [2000]
  • Antitumour effects of bisphosphonates: first evidence and possible mechanisms
    Diel IJ. Drugs 59 391-399 [2000]
  • Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
    Ottewell PD Mol Cancer Ther 8 : 2821 ~ 2832 [2009]
  • Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
    Ottewell PD Mol Cancer Ther 8 2821-2832 [2009]
  • Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
    Coleman RE Eur J Cancer 45 : 1909 ~ 1915 [2009]
  • Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
    Coleman RE Eur J Cancer 45 1909-1915 [2009]